Alumni raised $1.45B in 2022 - Download Free Report Now

Nuclea Biotechnologies

Gene-, protein-, and serum-based biomarker analysis technology to identify potential cancer.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Nuclea Biotechnologies plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Nuclea Biotechnologies

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With